What We're Reading: New WHO Leader; Drug Control Office Budget; Teaching Hospital Mortality
A First: FDA Approves Pembrolizumab for Tissue-Agnostic Indication
CGM Offers Confidence Boost for Those Managing Diabetes With Insulin Injections, Study Finds
Study Identifies Racial Disparity in Risk of Interval Colorectal Cancer
Four Tips to Help Healthcare Companies Reduce Their Risk of Cyber Attacks
Adding Home-Based Ventilation to COPD Therapy Can Prolong Time to Readmission, Death
Budget Document Confirms Medicaid Cuts, Planned Parenthood Funding Ban, Reports Say
What We're Reading: Calif. Single-Payer Cost; Breast Cancer Risks; Health IT Burnout
Getting From Patient Reports to Measured Performance
Multigene Testing Can Inform Predisposition to Inherited Prostate Cancer
CDC Finds Black Children More Likely to Die From Diabetes
Report Outlines Burden of Rare Cancers, Including Poorer Survival Rates
Reports: Trump Budget to Cut Medicaid; Healthcare Subsidies to Stay for 90 Days
What We're Reading: E-Cigarette Rule Delay; Metformin Safety; "Fittest City" Rankings
Value in Pharmacy Reaches "Inflection Point"
Trial Duration, Disease Severity Impact Discontinuation and COPD Exacerbation
Healthcare World Living "Month-to-Month" While Congress Debates Reform
Hotter Temperatures Linked to Increased Risk of Gestational Diabetes
Fight Over AHCA Just Getting Started, Leavitt Partners' Alspach Says
5 Priorities During National Women's Health Week
Study Identifies Patterns of Peer Pressure With Advanced Imaging in Breast Cancer
This Week in Managed Care: May 19, 2017
DOJ Alleges UnitedHealth Received More Than $1B for False Medicare Claims
What We're Reading: Paid Family Leave; Medical Devices Infiltrated; States Sue to Save ACA Funds
AJMC® in the Press, May 19, 2017
Alternative Payment Models in Oncology
Quality Is the "New Currency in Healthcare Delivery," UVA's Shannon Tells PQA
JAMA Finds Cardiac Deaths Drop; County-Level Data Reveal Clusters
Avalere and FasterCures Release Patient-Perspective Value Framework 1.0
FDA Expands Use of Kalydeco to Treat Cystic Fibrosis Caused by Rare Mutations